Clinical Trial Update: I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer [Phase 2]

View source ↗

Summary

This Clinical Trials update describes the I-SPY TRIAL, a Phase 2 neoadjuvant breast cancer study using personalized adaptive agents; recruitment is ongoing acro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma
• Breast Cancer
• Hormone Receptor-negative Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: QuantumLeap Healthcare Collaborative | Conditions: Breast Neoplasms, Breast Cancer | Phase 2 | Status: RECRUITING